Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Gonorrhea: early-phase trial registry

2 of 11 indexed Gonorrhea trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · 2 currently recruiting · #1,577 of 28,707 conditions by registered trial count

Gonorrhea: 11 US clinical trials tracked, 2 recruiting.

Gonorrhea is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Northwestern University, running 3 of these trials.

Enrollment posture brief

Registry condition gonorrhea

OPEN 2 | RECR 18% | LATE 2 | EARLY 4 | RANK #1577 | SPON 3

Nearest open-share peer: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome (18% recruiting · 22 trials)

Acute Pancreatitis81.8%Acute Stroke45.5%Acquired Brain Injury36.4%Gonorrhea (this)18%Acute Lung Injury9.1%
Open-enrollment share among volume-matched conditions near Gonorrhea

Gonorrhea lists 2 open slots (18% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Gonorrhea on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Gonorrhea is recruiting below its size-band peers.

    2 of 11 indexed trials (18.2%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Gonorrhea research.

    Northwestern University accounts for 3 of 11 trials (27.3%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Gonorrhea enrolment sits around 354 participants.

    Median target enrolment is 354 among the 11 trials that report a genuine target (sentinel values excluded). 3 of those (27.3%) plan for fewer than 100 participants.

  4. Gonorrhea research is mostly interventional.

    10 interventional and 1 observational studies make up this index (90.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 24Phase 32

Open and recent trials

11 total, page 1 of 1

RECRUITING NA 5,000 participants

Effectiveness of Relationship Education for Reducing HIV Incidence Among SGM

Northwestern University

NCT05678556

RECRUITING NA 75 participants

Assessing Acceptability and Feasibiity of STI Self-swab Testing, to be Offered at the Time of Telemed Medication Abortion Provision

Queen's Medical Center

NCT06951438

COMPLETED 7,128 participants

Evaluation of the Atlas Genetics io® CTNG System

Binx Health Limited

NCT03071510

COMPLETED Phase 3 628 participants

A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea

GlaxoSmithKline

NCT04010539

COMPLETED Phase 3 403 participants

Home Screening for Chlamydia Surveillance

University of Pittsburgh

NCT00177437

COMPLETED Phase 2 400 participants

Online HIV Prevention for Young Male Couples

Northwestern University

NCT03284541

COMPLETED NA 354 participants

Multimedia WORTH With Black Drug-Involved Women on Probation

Columbia University

NCT02391233

COMPLETED Phase 2 256 participants

Randomized Trial of an HIV Prevention and Relationship Education Program for Young Male Couples

Northwestern University

NCT03186534

COMPLETED Phase 2 106 participants

A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae

GlaxoSmithKline

NCT02294682

COMPLETED NA 75 participants

Zenyth: Motivational Interviewing-based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening

University of Michigan

NCT06100250

COMPLETED Phase 2 32 participants

Aztreonam for Pharyngeal Gonorrhea

University of Washington

NCT03867734

Phase Distribution

PhaseTrial count
Phase 2 4
Phase 3 2

Named interventions

Most-linked intervention names on Gonorrhea records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

2GETHER Behavioral
2 trials
Streamlined HIV Testing Behavioral
1 trials
E-WORTH Behavioral
1 trials
home testing kit Behavioral
1 trials
Positive Affect Enhancement Behavioral
1 trials
Aztreonam Drug
1 trials
Atlas Genetics io® system Device
1 trials
Motivational interviewing and specimen self-collection Behavioral
1 trials

US sites by state

Facility locations filed on Gonorrhea trials. A trial with sites in several states counts in each.

Pennsylvania 3 trials
Louisiana 3 trials
Indiana 3 trials
Illinois 3 trials
California 3 trials
Texas 2 trials
Ohio 2 trials
North Carolina 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Gonorrhea page

11 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Gonorrhea condition card totals 11 registered trials; most-linked intervention 2GETHER; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.